We've found
161,353
archived clinical trials in
Cancer
We've found
161,353
archived clinical trials in
Cancer
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Updated: 12/31/1969
Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
Updated: 12/31/1969
INST 0817: Compassionate Use of Mifepristone
Status: Enrolling
Updated: 12/31/1969
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
Updated: 12/31/1969
INST 0817: Compassionate Use of Mifepristone
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Updated: 12/31/1969
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Status: Enrolling
Updated: 12/31/1969
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Updated: 12/31/1969
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Expressive Disclosure and Colorectal Cancer
Updated: 12/31/1969
Expressive Disclosure Program for Colorectal Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Expressive Disclosure and Colorectal Cancer
Updated: 12/31/1969
Expressive Disclosure Program for Colorectal Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Expressive Disclosure and Colorectal Cancer
Updated: 12/31/1969
Expressive Disclosure Program for Colorectal Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Expressive Disclosure and Colorectal Cancer
Updated: 12/31/1969
Expressive Disclosure Program for Colorectal Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Updated: 12/31/1969
Open Label Phase II Trial of Bendamustine Hydrochloride (HCL) in Women With Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Updated: 12/31/1969
Open Label Phase II Trial of Bendamustine Hydrochloride (HCL) in Women With Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer
Updated: 12/31/1969
A Phase II Study to Determine the Efficacy of Tarceva® (Erlotinib Hydrochloride) With Concurrent Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 12/31/1969
Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer
Updated: 12/31/1969
A Phase II Study to Determine the Efficacy of Tarceva® (Erlotinib Hydrochloride) With Concurrent Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Status: Enrolling
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Status: Enrolling
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Status: Enrolling
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Updated: 12/31/1969
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Automated Pain Intervention for Underserved Minority Breast Cancer Patients
Updated: 12/31/1969
Automated Pain Intervention for Underserved Minority Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Automated Pain Intervention for Underserved Minority Breast Cancer Patients
Updated: 12/31/1969
Automated Pain Intervention for Underserved Minority Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
Updated: 12/31/1969
An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials